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Supplementary Materials and Methods  
Carbon nanotubes three-dimensional frame and spinal cord organotypic culture preparation 
Carbon nanotube three-dimensional frames (3D CNF) were obtained from Prof. Maurizio De 
Crescenzi’s laboratory (52). As previously reported (52, 54, 55), manufactured carbon nanotube 
freestanding frameworks were three-dimensional meshes of self-assembled, interconnected large 
multi-walled carbon nanotubes (MWCNT). MWCNTs were up to 0.4 µm in diameter and up to 
hundreds of µm in length, 3D CNF were obtained by chemical vapor deposition (CVD) as 
described in previous works (52, 54, 55). 3D CNFs were characterized by a bulky stiffness, 
measured by a compressive load cell, of about 5 kPa, a value within the range of the reported 
tissue stiffness for rodent and human brains (from 0.1 to 20 kPa) (56). 3D CNFs also displayed 
high electrical conductivity (52). The bulky 3D scaffolds were cut into thin square slices (3 mm 
× 4 mm lateral size; 250–400 µm thickness) and then secured on standard glass coverslips 
(Kindler) by PDMS (Sylgard® 184 silicone elastomer, Dow-Corning, US) cured at 150°C for 15 
minutes. Thereafter substrates were cleaned under low-pressure air plasma for 5 minutes (PDC-
32G Plasma Cleaner, Harrick Plasma) and UV sterilized for 20 minutes before use. 
 
Organotypic cultures were obtained from spinal cords of E12 embryonic mouse (C57Bl) as 
previously reported (8, 21, 26). Pregnant mice were sacrificed by CO2 overdose and decapitation 
and fetuses delivered by caesarean section. Isolated fetuses were decapitated and their backs 
were isolated from low thoracic and high lumbar regions and transversely sliced (275 μm) with a 
tissue chopper. After dissecting the spinal cord slices from the surrounding tissue, two of them 
were mounted on control glass coverslips (Control) or on 3D CNF attached to the coverslips, and 
arranged at a similar distance in both conditions, to interface slice growth. In both conditions, 
slices were embedded into a thick matrix obtained by chicken plasma (Rockland) and thrombin 
(Sigma) clot. Slices were cultured in plastic tubes with 1.5 mL medium containing 67% DMEM 
(Invitrogen), 8% sterile water for tissue culture, 25% fetal bovine serum (Invitrogen), and 25 
ng/mL nerve growth factor (Alomone Laboratories); osmolarity, 300 mOsm; pH 7.35. The tubes 
were kept in a roller drum rotating 120 times per hour in an incubator at 37°C in the presence of 
humidified atmosphere, with 5% CO2. Slices were cultured for 10–17 days. To ensure 
  
homogeneous experimental conditions between the two analyzed populations (Control and 3D 
CNF double explants), for electrophysiological and immunofluorescence experiments pairs of 
organotypic spinal explants with inter-slice distance (measured between the center of the two 
explants by bright field imaging) exceeding the 0.8–2.5 mm distance-range were discarded. 
 
Electrophysiological recordings  
Coverslips with spinal cultures were placed in a recording chamber, mounted on an upright 
microscope (Leica DM LFS), and superfused with Krebs' solution containing (in mM): 152 
NaCl, 4 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, and 10 Glucose. The pH was adjusted to 7.4 with 
NaOH. All experiments were performed at room temperature (RT; 20–22°C). Simultaneous 
extracellular recordings were obtained from the ventral area of each explant using low resistance 
glass micropipettes (4–6 M) filled with KCl (20 mM) solution; microelectrodes were 
positioned with micromanipulators (Luigs and Neumann SM1, Germany) and advanced into 
spinal tissue manually by micro-steps. The electrodes were usually placed in close proximity 
(20–100 m) to the ventral fissure, as this area, on both sides of the spinal cord, has been 
described as the prominent source of rhythmic activity in spinal slice cultures (57, 58). Voltage 
transients could be attributed to synaptic activity and action potential firing. Bursting activity 
was completely suppressed by bath-applied 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX; 10 
M) plus tetrodotoxin (TTX; 1M) in 100% of cases (n=13 explants, Control and 3D CNF; fig. 
S3B). The recorded signals were amplified (Axopatch 1D; Axon Instruments) and the offset of 
the traces was neutralized by current injection through the amplifier. Signals were recorded using 
the Clampex 8.2 software (pClamp suite, Axon Instruments) and acquired digitized (Digidata 
1322A, Axon Instruments) at 10 kHz, filtered at 2 kHz and stored on a PC. Disinhibited 
rhythmic bursts were obtained by bath co-application of strychnine and bicuculline (1 µM and 20 
µM, respectively)(20). Extracellular electrical stimulation was performed by placing a low-
resistance patch pipette containing external bath solution in the dorsal horn of one explant, 
ipsilateral to the ventral area being recorded. Short current pulses (200 s) of various amplitudes 
(i.e. the amplitude able to elicit the appearance of a voltage burst response in the ipsilateral 
ventral region in 100% of stimuli; ranges 100–500 μA; sample in fig. S3A), were delivered by a 
STG4002 stimulator (Multichannel Systems). 
 
  
Recordings were off-line, lowpass-filtered at 20 Hz for spontaneous activity analysis, and for 
disinhibited bursts analysis at 100 Hz (cross-entrainment analysis) or 3 Hz (cross-correlation and 
inter-event interval analysis). To evaluate the frequency of spontaneous voltage transients (in the 
absence of any pharmacological treatment or electrical stimulation), only the events with peak 
amplitudes above threshold (set to three times the baseline noise) were included. Disinhibited 
bursts occurrence was evaluated by measuring the mean inter-event interval (IEI; i.e. the time 
between the beginning of one burst and the beginning of the following one; >25 bursts for each 
measure).  
 
We further assessed the synchrony between the bursting activities of the two explants in each 
pair by computing the Pearson correlation coefficient between the two voltage time series as 
follows: in the experiments in which the Control slices were compared to 3D CNF slices (see 
Fig.  3A-D) or to 2D MWCNTs and 3D-PDMS (see fig. S2), the statistical significance of the 
correlation coefficient was determined by performing a permutation test (see fig.  S1). For each 
pair of time series, we randomly sampled time windows of consecutive data points of size s = 
N/5 (where N is the total number of data points of the time series), and, for each window, we 
computed the Pearson correlation coefficient between the resulting chunks of time series (see the 
example in fig.  S1A, where the dashed lines indicate the extremes of a randomly sampled time 
window and the gray traces indicate the portions of the time series that were used to compute the 
correlation coefficient). This procedure was repeated 104 times, thus yielding 104 correlation 
coefficients that were averaged to obtain an estimate of the correlation between the two time 
series (for the sample of time series shown in fig. S1A, the resulting average correlation 
coefficient is shown by the red line in the plot of fig. S1C). This value was compared to the null 
distribution of correlation coefficients that was obtained by taking time windows of consecutive 
data points of the same size s as before, but with the onsets of the time windows that were 
independently, randomly sampled for the two time series (see, as an example, the gray portions 
of the time series in fig. S1B). Again, this procedure was repeated 104 times, yielding the 
distribution of correlation coefficients that one would expect to observe if the voltage signals 
recorded from a pair of explants happened to correlate purely by chance, even in absence of 
synchrony (see the histogram in fig. S1C). By measuring how likely it was for the values of this 
null distribution to be larger or equal than the real correlation coefficient (i.e., for the values of 
  
the histogram in fig. S1C to be larger than the red line), it was possible to understand whether the 
correlation between the pair of time series was significantly larger than expected by chance (with 
P=0.05). Since, in general, two time series could be anti-correlated as well as correlated, the 
same test was applied to the left tail of the null distribution, in case the measured correlation 
coefficient was negative (i.e., we checked how likely it was for the values of the null distribution 
to be smaller or equal than the measured correlation coefficient). This procedure allowed for 
determining what fraction of co-cultured slices exhibited a significantly synchronous bursting 
activity, for all the tested conditions. The resulting fractions of significantly synchronous slices 
were then compared by performing a homogeneity test with the chi-squared method (shown in 
Fig. 3D). For the stimulation-based experiments (Fig. 3E-G), the bursting activities of two 
explants in a pair were considered synchronous, when the magnitude of their CCF was larger 
than 0.5. 
 
Immunofluorescence labeling and confocal imaging of spinal slice explants 
Following electrophysiological recordings, spinal organotypic cultures were fixed with 4% 
formaldehyde (prepared from fresh paraformaldehyde; Sigma) in PBS. Coverslips were rinsed 
with PBS. Free aldehyde groups were quenched in 0.1 M glycine in PBS for 5 minutes. The 
samples were incubated for 30 minutes in a blocking solution (5% BSA, Sigma, 0.3% Triton X-
100, Carlo Erba, 1% Fetal Bovine Serum, Gibco, in PBS), then incubated with anti-β-tubulin III 
primary antibody (rabbit polyclonal; 1:250, Sigma) and SMI-32 primary antibody (mouse anti-
neurofilament H antibody, 1:200, Sternberger Monoclonals Inc.) diluted in PBS with 5% FBS at 
4°C, overnight. After subsequent washing in PBS, samples were incubated in secondary 
antibodies (goat anti-mouse Alexa 488, Invitrogen, 1:500; goat anti-rabbit Alexa 594, Invitrogen, 
1:500; DAPI, Invitrogen 1:500) for 2 h at room temperature. Following secondary antibody 
incubation, samples were washed in PBS and briefly rinsed with water and mounted on glass 
coverslips using Vectashield hardset mounting medium (Vector laboratories). 
 
Images were acquired using Nikon C2 or Leica DMIRE2 Confocal microscopes, both equipped 
with Ar/Kr, He/Ne, and UV lasers. Images were acquired with a 40× or 63× oil objective 
(numerical aperture 1.4) using oil mounting medium (1.515 refractive index). Confocal sections 
were acquired every 1 μm and the total Z-stack thickness was set such that all emitted 
  
fluorescence was collected from the sample. In order to visualize the 3D CNF scaffold along 
with the immunolabeled components, the reflection mode setting (excitation with the 488 nm 
laser line and acquisition of the reflected signal in the 460–500 nm range) available in the Leica 
confocal microscope was utilized. Analysis and 3D reconstruction of the image Z-stacks were 
accomplished using one of the following softwares: NIS-Elements AR (Nikon), Volocity 
(PerkinElmer), and FIJI (http://fiji.sc/Fiji).  
 
Analysis of fiber outgrowth morphology was performed by selecting random regions of 160 m 
per 160 m of visual field dimension at 40× magnification. To visualize and appreciate the 
difference in the 3D distribution of the neuronal processes in Control and 3D CNF networks, the 
three-dimensional extent of the processes was also visualized by color-coding for the thickness 
through which they extended; FIJI and MATLAB software packages were employed for this 
analysis. The Z-stacks of representative neuronal processes extensions were first viewed using 
FIJI and color-coded for the thickness by using the Temporal-color code command in the 
Hyperstacks section of the software. The images obtained were then visualized in MATLAB and 
the figure color-map was set such that for both conditions, the color depth demonstrated equal 
thickness, thus ensuring homogeneity in the color scheme in Control and 3D CNF. To quantify 
the distribution of neuron processes along the thickness of the image stack, 9 regions from 6 
coverslips of Control and 14 regions from 5 coverslips of 3D CNF were compared. The thickness 
through which the immunolabeled processes were distributed was calculated (using FIJI) and the 
statistical differences between the datasets were assessed by Student's t test (after validation of 
variances homogeneity by Levene's test; Statistica software). 
 
In order to rule out any possible discrepancy in the fluorescence emission due to the 3D scaffold, 
images of fluorescent beads (2 m biodegradable micro-particles from Kisker, PBD-GF-2.0; a 
kind gift from Dr. Dan Cojoc, CNR-IOM, Trieste) deposited on glass and on 3D CNF were 
acquired using identical settings. The intensity of the fluorescence was analyzed using the 




Brain tissue implantation with 3D CNF  
The implant consisted of a sharp-pointed cylinder (2 mm length, 0.5±0.2 mm in diameter) 
carved out of a larger 3D CNF scaffold and mounted on an electrode holder (ZIF-Clip®, Tucker-
Davis Technologies, USA). Scaffold stiffness was increased before carving procedure in order to 
facilitate the insertion of the material into the brain tissue. This stiffening was achieved by filling 
the scaffold with water-soluble polyethylene glycol (PEG), a biocompatible polymeric material 
commonly used for implants and hydrogels (59, 60). Briefly, the 3D CNF scaffold was dipped 
into melted PEG-4000 (Poly(ethylene glycol); 81240 from Sigma Aldrich, average MW 4,000 
Da) at 65°C. PEG molecules permeate the scaffold, filling all empty spaces. The sample was 
allowed to cool to RT and shaped with a razor blade. To facilitate handling and positioning 
during the surgical procedure, the scaffold was fixed to the electrode holder using PEG. 
 
All surgical procedures were performed on Wistar male rats (Harlan Laboratories), 3–6 months 
of age and weighing 450–550 gr. Anesthesia was induced and maintained with Isofluorane (2% 
in 100% O2, Sigma Aldrich) administered via a nose cone throughout the procedure. Anesthetic 
depth was monitored by checking the absence of tail and paw reflexes. The anesthetized animal 
was placed in a stereotaxic apparatus (Narishige SR-5R, Japan) to measure the exact location of 
the craniotomy and the penetration site. Body temperature was maintained at 37°C with a 
thermostatically controlled heating pad (temperature control unit HB 101/2; Panlab/Harvard 
Apparatus, Barcelona, Spain) to avoid anesthesia-induced hypothermia. Heart rate and oxygen 
saturation level were constantly monitored via a pulse oxymeter (Pulsesense LS1P-10R, Nonin 
Medical Inc, Medair AB, Hudiksvall, Sweden). A square, 2 mm  2 mm craniotomy was 
performed over the left hemisphere using a micro drill and the dura mater was removed, 
exposing the brain. Tissue adhesive (B. Braun Aeusculap, Germany) was applied on the inner 
perimeter of the craniotomy to prevent brain dimpling. 
 
The PEG-stiffened 3D CNF scaffold was inserted at –4.5 mm from Bregma (in the anterior-
posterior axis) and –3.5 mm in the medial-lateral axis. These coordinates refer, in the adult rat, to 
the visual cortex, specifically to the cortical junction between V2ML and V1 (61). 3D CNF 
scaffold was quickly placed into the cortex via a micro-drive at a speed of insertion of about 0.5 
mm/s in order to prevent premature PEG melting. When the desired depth was reached, i.e. the 
  
sponge penetrated the cerebral tissue for approximately its whole length (~2 mm in the dorsal-
ventral axis), the craniotomy was filled with silicone (Kwik-Cast&Kwik-sil, World Precision 
Instrument, USA) in order to isolate the exposed brain tissue, and the whole skull surface 
covered by bone cement (Super Bond, C&B, USA). 
 
Throughout the whole procedure, both rat eyes and cortex were periodically irrigated, using an 
ophthalmic solution (Epigel, CevaVetem, Italy), and a 0.9% NaCl saline solution, respectively. 
Atropine (1.5 mg/kg, subcutaneous) and Lactated Ringer’s Solution (1 mL, subcutaneous) were 
administered every hour, to reduce secretions and maintain the animal’s physiological state. 
Analgesic solution (Rymadyl; 5 mg/kg, intraperitoneal) and antibiotic (Baytril; 5 mg/kg, 
intramuscular) were administered to the rat via injection, immediately before the surgery and one 
hour prior to the end of the surgical procedure. Both solutions were administered following 
surgery via the animals’ drinking water for three days post-surgery.  Animals were monitored for 
recovery immediately after the surgery and at least 3 times per day for the first 72 h. We used a 
general distress-scoring sheet (Institutional Standards for the Care and Use of Animals in 
Research and after consulting with a veterinarian) to assess pain and distress in animals using 
physiological (appearance) and behavioral (natural and provoked behavior) parameters. For each 
parameter a numerical score starting from 0=normal and reaching 3=grossly abnormal is 
determined. An extra point is added for each 3 given. The provoked behavior was tested first 
after 72 h post-implantation. This method allows an objective monitoring of animals general 
conditions, to evaluate the need of analgesics or euthanization. All the animals used in the study 
did not show any sign of pain or distress (score=0). Following this 72 h period, animals were 
monitored once per day until sacrifice.  
 
Brain tissue preparation, immunohistochemistry, image acquisition, and analysis 
Animals were sacrificed at 4 weeks post-implantation and, in an exploratory longitudinal study, 
at five different post-implantation time points, as follows: 0 weeks (in which the animal was 
euthanized immediately after the implantation, “acute”), 1 week, 2 weeks, 4 weeks and 8 weeks. 
Animals were anesthetized with 5% chloral hydrate (7 mL/kg) and then perfused transcardially 
with 0.1 M PBS followed by 4% PFA in PBS. Brains were removed, postfixed for 24 h at 4°C, 
and cryoprotected in 15% sucrose in PBS at 4°C for 24 h and then in 30% sucrose in PBS at 4°C 
  
for at least 24 h. Finally, brains were embedded in optimal cutting temperature (OCT) compound 
(Tissue-Tek), frozen at –20°C, and cryosectioned horizontally in 25 μm thick sections. 
 
Tissue-Tek was removed by PBS washing and tissue sections were incubated 5 min in glycine 
0.1 M and blocked in 3% BSA, 3% FBS, 0.3% Triton X-100 in PBS for 30 min at room 
temperature followed by incubation overnight at 4°C with primary antibodies (mouse anti-
GFAP, 1:200, Sigma; rabbit anti-Iba1, 1:400, Wako; rabbit anti-β-tubulin III, 1:250, Sigma; 
mouse anti-NeuN, 1:100, Millipore; mouse anti-CD68/ED1, 1:100, AbD Serotec; rabbit anti-
CX3CR1, 1:200, Sigma) in 5% FBS in PBS. After washing in PBS, sections were incubated in 
secondary antibodies (goat anti-rabbit Alexa 594, 1:500, Invitrogen; goat anti-mouse Alexa 488, 
1:500, Invitrogen; DAPI, 1:200, Invitrogen) in 5% FBS in PBS for 2 h at room temperature. 
Sections were mounted on glass coverslips using Vectashield hard mounting medium (Vector 
Laboratories). 
 
We measured the brain tissue reaction at specific time after implants by markers for reactive 
astrocytes, with glial fibrillary acidic protein (GFAP), for microglia with ionized calcium-
binding adaptor protein-1 (Iba1), and for neurons (-tubulin III; NeuN). In order to quantify 
GFAP and Iba1 labeling, fluorescence images were acquired using a Leica DM6000 upright 
microscope with a 10× dry objective. Identical binning, gains and exposure times were used for 
all images of the same marker. Image analysis was performed using the FIJI software. Different 
quantification methods were used for GFAP and Iba1 labeling. For GFAP, eight regions of 
interest (ROIs; 100 µm  500 µm) were drawn at random intervals around the implant, starting 
from the edge of the implant and extending 500 μm into the surrounding tissue. Within each 
ROI, three intensity profile lines were selected blindly in order to obtain a fluorescence intensity 
profile as a function of distance from the implant edge. To account for variations in labeling, the 
fluorescence intensity in the contralateral hemisphere was defined as the background intensity 
for each brain section and normalized to 1(37). The mean intensity profile for each animal was 
calculated for each micron of 0–150 μm from the implant edge. Because differences in GFAP 
intensity were within a maximum of 50 μm from the implant, the data from 0-150 μm were 
further normalized to the mean intensity for 51–150 μm.  
  
In the longitudinal study (n=1 animal per time point; fig. S5) the mean GFAP fluorescence 
intensity in the 0–50 μm ROI was increased from 4 to 8 weeks post-implantation (1.07±0.13 and 
1.05±0.11 normalized intensity/μm, respectively; n=56 and 80 ROIs) compared to 0, 1, and 2 
weeks post implantation (0.94±0.10, 0.92±0.14, and 0.94±0.12 normalized intensity/μm, 
respectively; n=40 ROIs for 0 and 1 weeks, n=64 ROIs for 2 weeks; fig. S5A-B). 
 
For Iba1 labeling, eight 100 μm × 500 μm ROIs were selected starting from the edge of the 
implant and extending 500 μm into the surrounding tissue. The background intensity threshold 
was defined for each tissue section using the Iba1 labeling intensity measured in the contralateral 
hemisphere in the same anatomical region as the implanted material. The area within each ROI 
with intensity above the background threshold was calculated.  
 
In the longitudinal study, the Iba1 immunoreactivity was greatly increased at 1 week post-
implantation compared to the acute/ 0 weeks (Iba1-positive area/total area: 0.34±0.18 and 
0.043±0.02, respectively; n=32 and 32 ROIs, fig. S5C-D). Furthermore, microglia cells were 
clearly invading the 3D CNF. At 2 and 4 weeks post-implantation, the Iba1 labeling was still 
increased compared to the acute/0 weeks post-implantation (Iba1-positive area/total area: 
0.089±0.06, n=64 ROIs, P=0.018 and 0.16±0.11, n=40 ROIs); however, the reactivity at these 
time points was reduced compared to the 1 week post-implantation tissue, meaning that 
microglia surrounding the implanted material were primarily active in the first week following 
the implantation and then activation declined with time. This was further confirmed at 8 weeks 
post-implantation, in which the Iba1 labeling around the implant (Iba1-positive area/total area: 
0.04±0.03, n=64 ROIs) returned to baseline condition. 
 
In addition to the GFAP and Iba1 analysis of the animals at 4 weeks post-implantation, we 
analyzed the tissue for CX3CR1 and CD68/ED1, markers of inflammation and reactive 
astrocytes (data not shown). For this analysis, three 150 μm × 150 μm ROIs were selected within 
each 3D CNF scaffold. The background intensity threshold was defined for each tissue section 
using the corresponding labeling intensity measured in the contralateral hemisphere in the same 
anatomical region as the implanted material. The area within each ROI with intensity above the 
background threshold was calculated. We performed this analysis on animals sacrificed at 4 
  
weeks post-implantation. The average values obtained for CX3CR1 (CX3CR1-positive area/total 
area: 0.32±0.23, n=18 ROIs) and CD68/ED1 (CD68/ED1-positive area/total area: 0.12±0.17, 
n=18 ROIs) represent the 36% and 13% of the total amount of microglia cells (calculated in the 
same way based on Iba1 labeling), respectively, indicating a relatively low percentage of reactive 
microglia inside the 3D CNF scaffold. Moreover, CD68/ED1-positive cells were totally absent in 
the surrounding tissue. 
 
Confocal images of brain tissue sections were acquired and processed using the same equipment 
and procedures as the spinal slice explants, as described above. 
 
Scanning Electron Microscopy 
3D CNF morphology was qualitatively assessed through scanning electron microscopy (SEM). 
Images were acquired collecting secondary electrons on a Gemini SUPRA 40 SEM (Carl Zeiss 
NTS GmbH, Oberkochen). Bare scaffolds were mounted on conductive double side carbon tape 
(Ted Pella, Inc., USA) and imaged at 5 keV.  
 
Mechanical characterization 
For compressive tests, cubic samples of 3D CNF scaffolds were used, with a dimension of 5 mm 
per side. Uniaxial micro-compression tests were conducted on a Galdabini SUN 500 apparatus. 
Before compressive testing, a 0.01 N preload was applied to ensure a complete contact between 
the sample and the two flat surfaces compressing it. A constant speed (15 µm/s) loading cycle 
was used with a load limit fixed at 10 N. After the limit was reached, we recorded discharging 
cycle to point out potential sample plastic deformation. Final peak displacement was about 3 
mm. Scaffolds were indented using a 20 mm flat punch using a high sensitivity load cell for data 
collection (CTCA10K5 – AEP Transducers, Italy). Tests were operated at room temperature in 
air. Elastic data were determined by calculating the initial linear slope of the stress-strain curve. 
  
  
  
 
  
 
 
 
  
 
 
  
 
